Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 1
3(75.0%)
N/A
1(25.0%)
4Total
Phase 1(3)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT03549780Not ApplicableCompleted

Novel Stomal Occlusion Device in Patients With a Brooke Ileostomy

Role: lead

NCT03209700Phase 1Completed

Re-treatment From a Phase I Study of MSC-AFP in Patients With Perianal Fistulas

Role: lead

NCT01915927Phase 1Completed

Stem Cell Fistula Plug in Perianal Crohn's Disease

Role: lead

NCT03014219Phase 1Withdrawn

Phase 1 Crohn's Pediatric Sub-study of MSC AFP

Role: lead

All 4 trials loaded